It may be assumed that both metabolic syndrome and psoriasis increase the synthesis and release of clusterin, compared to normal conditions, but the factors associated with metabolic syndrome might lower the level of clusterin, compared to that in psoriasis alone. This evidence concerns the gene CLU and psoriasis.